Cost-of-illness of knee osteoarthritis: potential cost savings by not undergoing arthroplasty within the first 2 years.

Ong, Kevin L; Runa, Maria; Lau, Edmund; Altman, Roy D

Ong, Kevin L; Runa, Maria; Lau, Edmund; Altman, Roy D.

Afiliação

Ong KL; Biomedical Engineering, Exponent, Inc, Philadelphia, PA, USA, kong@exponent.com.
Runa M; Biomedical Engineering, Exponent, Inc, Philadelphia, PA, USA, kong@exponent.com.
Lau E; Health Sciences, Exponent, Inc, Menlo Park, CA, USA.
Altman RD; School of Medicine, University of California, Los Angeles, CA, USA.

Clinicoecon Outcomes Res ; 11: 245-255, 2019.

Article em En | MEDLINE | ID: mdl-30936730

Palavras-chave

health care expenditures; hyaluronic acid; intra-articular injections; knee arthroplasty

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Temas: ECOS / Financiamentos_gastos Bases de dados: MEDLINE Tipo de estudo: Health_economic_evaluation Idioma: En Revista: Clinicoecon Outcomes Res Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google